Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Penile Neoplasms × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Cyclophosphamide 2 rocakinogene sifuplasmid 1 durvalumab 1 VGX-3100 1 Surveys and Questionnaires 1 Sildenafil Citrate 1 Paclitaxel 1 MEDI0457 1 Interleukin-2 1 Immunoglobulin G 1 Ifosfamide 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Fentanyl 1 Disulfides 1 Cisplatin 1 Alprostadil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡